ISI Web of Knowledge Take the next step  
Web of Science®
 
Previous Record (inactive) Record 1  of  1 Next Record (inactive)
Record from Web of Science®
Extensive analysis of the 13q14 region in human prostate tumors: DNA analysis and quantitative expression of genes lying in the interval of deletion
Author(s): Latil A, Chene L, Mangin P, Fournier G, Berthon P, Cussenot O
Source: PROSTATE    Volume: 57    Issue: 1    Pages: 39-50    Published: SEP 15 2003  
Times Cited: 17     References: 32     
Abstract: BACKGROUND. Loss of heterozygosity (LOH) on chromosome arm 13q14 is one of the most consistent genetic alterations in sporadic prostate cancer. This alteration may be involved in prostate oncogenesis through inactivation of one or more tumor suppressor genes (TSGs). Candidate gene expression is an approach to focus the search for TSGs in this region.

METHODS. We tested 41 human sporadic prostate tumors for 13q14 LOH by using seven polymorphic markers overlapping the critical region and used a real-time quantitative RT-PCR assay to study the same tumors for expression of the 31 genes located in this genomic region (localized by the Human Genome Project Working Draft).

RESULTS. Allelic loss on at least one locus was found in 18 (41%) of the 41 tumor DNAs. Only four genes (ITM2B, CHC1L, KIAA0970, and LOC51131), located in the region most frequently deleted in prostate carcinoma, showed a significant difference in expression between normal and neoplastic prostate tissues.

CONCLUSIONS. Given their location in the LOH hotspot, as indicated by our genomic analysis, ITM2B, CHC1L, KIAA0970, and LOC51131 are candidate tumor suppressor genes in this region. ITM2B that showed a significant association (P < 0.005) between expression and LOH at the corresponding locus could, furthermore, be the main target of the observed LOH at 13q in prostate tumors. (C) 2003 Wiley-Liss, Inc.

Document Type: Article
Language: English
Reprint Address: Latil, A (reprint author), UroGene, 4 Rue Pierre Fontaine, F-91058 Evry, France
Addresses:
1. UroGene, F-91058 Evry, France
2. Fac Med, EA3104, CeRePP, F-75006 Paris, France
3. Hop Brabois, F-54500 Vandoeuvre Les Nancy, France
4. Hop Cavale Blanche, F-29609 Brest, France
5. Univ Paris 07, Hop St Louis, Dept Urol, F-75010 Paris, France
6. Inst Univ France, F-75005 Paris, France
Publisher: WILEY-LISS, DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
Subject Category: Endocrinology & Metabolism; Urology & Nephrology
IDS Number: 716MG
ISSN: 0270-4137
DOI: 10.1002/pros.10272
Previous Record (inactive) Record 1  of  1 Next Record (inactive)
Record from Web of Science®
  
Thomson Reuters Logo